Page 30 - பல்கலைக்கழகம் மருத்துவமனை பேசல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail Researchers from the University Hospitals in Zurich and Basel, ETH Zurich, University of Zurich and the pharmaceutical company Roche have set out to improve cancer diagnostics by developing a platform of state-of-the-art molecular biology methods. The Tumor Profiler project aims to derive the comprehensive molecular profile of tumours in cancer patients, which has the potential to predict the efficacy of a host of new cancer medications. It will therefore make it possible to offer treating physicians personalised and improved therapy recommendations. Three years ago, the researchers began a large-scale clinical study involving 240 patients suffering from metastatic skin cancer (melanoma), metastatic ovarian cancer, or acute myeloid leukaemia. The thorough investigation of these patients tumours provides the researchers with a comprehensive understanding of the cellular composition and biology of each tumour. The researchers recently published details of their study desi

Mitch levesqueAndreas wickiViola heinzelmannUniversity hospital zurichUniversity hospitals in zurichUniversity hospital baselUniversity of zurichUniversity hospitalsUniversity hospitalTumor profilerGynecological oncologyமிட்ச் லெவெஸ்‌க்வயல ஹெய்ன்செல்மேன்பல்கலைக்கழகம் மருத்துவமனை ஸுரிபல்கலைக்கழகம் மருத்துவமனைகள் இல் ஸுரிபல்கலைக்கழகம் மருத்துவமனை பேசல்